LOSS OF NONPHOSPHORYLATED NEUROFILAMENT IMMUNOREACTIVITY, WITH PRESERVATION OF TYROSINE-HYDROXYLASE, IN SURVIVING SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE
Wp. Gai et al., LOSS OF NONPHOSPHORYLATED NEUROFILAMENT IMMUNOREACTIVITY, WITH PRESERVATION OF TYROSINE-HYDROXYLASE, IN SURVIVING SUBSTANTIA-NIGRA NEURONS IN PARKINSONS-DISEASE, Journal of Neurology, Neurosurgery and Psychiatry, 57(9), 1994, pp. 1039-1046
The distribution of neurofilament immunoreactivity in the substantia n
igra was examined by immunohistochemistry in five patients dying with
Parkinson's disease and six control patients dying without neurologica
l disease. In controls, pigmented neurons in the substantia nigra were
intensively labelled by SMI32, a monoclonal antibody to non-phosphory
lated neurofilament protein. In the substantia nigra from patients who
had Parkinson's disease, there was a pronounced reduction of SMI32 la
belling intensity in surviving pigmented neurons. By contrast, tyrosin
e hydroxylase immunoreactivity in surviving pigmented neurons was norm
al. SMI32 labelling was normal in regions of the brainstem not affecte
d by the neuropathological process of Parkinson's disease. Findings wi
th either antibodies to phosphorylated neurofilament, or enzymatic dep
hosphorylation followed by SMI32 labelling, indicated that loss of SMI
32 immunostaining in Parkinson's disease was not due to masking of the
neurofilament epitopes by phosphorylation. Our results indicate that
neurofilament proteins are particularly likely to be disrupted or dest
royed by the neuropathological process of Parkinson's disease. Neverth
eless, the normal appearance of tyrosine hydroxylase indicates that pr
otein synthesising systems may be intact in surviving neurons. Loss of
neurofilament immunoreactivity may prove a sensitive neuropathologica
l marker for characterisation of degenerating neurons in Parkinson's d
isease.